A Manchester man hospitalised with COVID-19 in the early days of the pandemic is now giving back to the NHS by taking part in research – and is encouraging others to do the same.
Read more
Cellular (T-cell) immunity against SARS-CoV-2 is likely to be present within most adults for at least six months after infection, according to research carried out at MFT.
Read more
More than 600 school children and teachers in Greater Manchester have taken part in a new voluntary coronavirus study, which is assessing the prevalence of COVID-19 in school pupils and teachers.
Read more
Our first patient has taken part in a new clinical trial investigating potential treatments for COVID-19, as part of a nationwide research effort to meet the challenge of coronavirus.
Read more
Our first patient has participated in the RUXCOVID research trial, which is testing whether the drug ruxolitinib could be a potential treatment for COVID-19 (coronavirus).
Read more
Staff at MFT, already caring for patients on the frontline, are now helping fight the battle against COVID-19 by taking part in research
Read more
MFT has recruited more than 400 patients to research trials in an attempt to better understand and treat COVID-19.
Read more
In an unprecedented move, scientists and clinicians across Greater Manchester have formed a Rapid Response Research Group to find ways to beat COVID-19 and save lives.
Read more
